-
1
Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
Published 2019-02-01Subjects: “…renin-angiotensin-aldosterone system blockers…”
Get full text
Article -
2
Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
Published 2023-06-01Subjects: Get full text
Article -
3
-
4
Exposure to renin-angiotensin system inhibitors before kidney transplantation is associated with a decreased risk of delayed graft function
Published 2024-11-01Subjects: “…renin-angiotensin-aldosterone system blockers…”
Get full text
Article -
5
PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
Published 2017-11-01Subjects: Get full text
Article -
6
Systematic Review and Meta-Analysis of Renin–Angiotensin–Aldosterone System Blocker Effects on the Development of Cardiovascular Disease in Patients With Chronic Kidney Disease
Published 2021-07-01Subjects: “…renin-angiotensin-aldosterone system blocker…”
Get full text
Article -
7
Evaluation of modifiable risk factors for peritoneal dialysis-related peritonitis: a single-center retrospective cohort study
Published 2021-05-01Subjects: Get full text
Article -
8
Prescription of quadruple therapy in heart failure with reduced ejection fraction during hospitalization
Published 2024-10-01Subjects: Get full text
Article